BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34224807)

  • 1. Cellular binding and uptake of fluorescent glucose analogs 2-NBDG and 6-NBDG occurs independent of membrane glucose transporters.
    Hamilton KE; Bouwer MF; Louters LL; Looyenga BD
    Biochimie; 2021 Nov; 190():1-11. PubMed ID: 34224807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fluorescence method for measurement of glucose transport in kidney cells.
    Blodgett AB; Kothinti RK; Kamyshko I; Petering DH; Kumar S; Tabatabai NM
    Diabetes Technol Ther; 2011 Jul; 13(7):743-51. PubMed ID: 21510766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose metabolism down-regulates the uptake of 6-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose (6-NBDG) mediated by glucose transporter 1 isoform (GLUT1): theory and simulations using the symmetric four-state carrier model.
    DiNuzzo M; Giove F; Maraviglia B; Mangia S
    J Neurochem; 2013 Apr; 125(2):236-46. PubMed ID: 23336592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of fluorescent D- and L-glucose analogues, 2-NBDG and 2-NBDLG, into human osteosarcoma U2OS cells in a phloretin-inhibitable manner.
    Ogawa T; Sasaki A; Ono K; Ohshika S; Ishibashi Y; Yamada K
    Hum Cell; 2021 Mar; 34(2):634-643. PubMed ID: 33454890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamate triggers rapid glucose transport stimulation in astrocytes as evidenced by real-time confocal microscopy.
    Loaiza A; Porras OH; Barros LF
    J Neurosci; 2003 Aug; 23(19):7337-42. PubMed ID: 12917367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of a fluorescent deoxyglucose analog (2-NBDG) in tumor cells.
    O'Neil RG; Wu L; Mullani N
    Mol Imaging Biol; 2005; 7(6):388-92. PubMed ID: 16284704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic validation of 6-NBDG as a probe for the glucose transporter GLUT1 in astrocytes.
    Barros LF; Bittner CX; Loaiza A; Ruminot I; Larenas V; Moldenhauer H; OyarzĂșn C; Alvarez M
    J Neurochem; 2009 May; 109 Suppl 1():94-100. PubMed ID: 19393014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel fluorescent derivative of glucose applicable to the assessment of glucose uptake activity of Escherichia coli.
    Yoshioka K; Takahashi H; Homma T; Saito M; Oh KB; Nemoto Y; Matsuoka H
    Biochim Biophys Acta; 1996 Feb; 1289(1):5-9. PubMed ID: 8605231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of glucose uptake by single Escherichia coli cells.
    Natarajan A; Srienc F
    Metab Eng; 1999 Oct; 1(4):320-33. PubMed ID: 10937825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining glucose transport in single vascular smooth muscle cells with a fluorescent glucose analog.
    Lloyd PG; Hardin CD; Sturek M
    Physiol Res; 1999; 48(6):401-10. PubMed ID: 10783904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Uptake of 2-NBDG by human breast cancer cells in vitro].
    Hu H; Shan XH; Zhu W; Qian H; Xu WR; Wang YF
    Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):507-10. PubMed ID: 21029693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular fate of 2-NBDG, a fluorescent probe for glucose uptake activity, in Escherichia coli cells.
    Yoshioka K; Saito M; Oh KB; Nemoto Y; Matsuoka H; Natsume M; Abe H
    Biosci Biotechnol Biochem; 1996 Nov; 60(11):1899-901. PubMed ID: 8987871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing glucose uptake through the yeast hexose transporter 1 (Hxt1).
    Roy A; Dement AD; Cho KH; Kim JH
    PLoS One; 2015; 10(3):e0121985. PubMed ID: 25816250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a novel non-radioactive cell-based method for the screening of SGLT1 and SGLT2 inhibitors using 1-NBDG.
    Chang HC; Yang SF; Huang CC; Lin TS; Liang PH; Lin CJ; Hsu LC
    Mol Biosyst; 2013 Aug; 9(8):2010-20. PubMed ID: 23657801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A real-time method of imaging glucose uptake in single, living mammalian cells.
    Yamada K; Saito M; Matsuoka H; Inagaki N
    Nat Protoc; 2007; 2(3):753-62. PubMed ID: 17406637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of 2-NBDG as a method to monitor therapy response in breast cancer cell lines.
    Millon SR; Ostrander JH; Brown JQ; Raheja A; Seewaldt VL; Ramanujam N
    Breast Cancer Res Treat; 2011 Feb; 126(1):55-62. PubMed ID: 20390344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of 2-NBDG, a probe for glucose uptake, in GLUT1 overexpression in HEK293T cells by LC-MS/MS.
    Sun Y; Hu M; Wang F; Tan H; Hu J; Wang X; Wang B; Hu J; Li Y
    Anal Biochem; 2021 Oct; 631():114357. PubMed ID: 34469746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery rate affects uptake of a fluorescent glucose analog in murine metastatic breast cancer.
    Rajaram N; Frees AE; Fontanella AN; Zhong J; Hansen K; Dewhirst MW; Ramanujam N
    PLoS One; 2013; 8(10):e76524. PubMed ID: 24204635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syntheses of 2-NBDG analogues for monitoring stereoselective uptake of D-glucose.
    Yamamoto T; Tanaka S; Suga S; Watanabe S; Nagatomo K; Sasaki A; Nishiuchi Y; Teshima T; Yamada K
    Bioorg Med Chem Lett; 2011 Jul; 21(13):4088-96. PubMed ID: 21636274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant Uptake of a Fluorescent L-Glucose Analogue (fLG) into Tumor Cells Expressing Malignant Phenotypes.
    Yamada K
    Biol Pharm Bull; 2018; 41(10):1508-1516. PubMed ID: 30270319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.